The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
Open accessAbstract
The effectiveness of anticancer agents may be hindered by low solubility in water, poor permeability, and high efflux from cells. Nanomaterials have been used to enable drug delivery with lower toxicity to healthy cells and enhanced drug delivery to tumor cells. Different nanoparticles have been developed using different polymers with or without surface modification to target tumor cells both passively and/or actively. Polylactide-co-glycolide (PLGA), a biodegradable polyester approved for human use, has been used extensively. Here we report on recent developments concerning PLGA nanoparticles prepared for cancer treatment. We review the methods used for the preparation and characterization of PLGA nanoparticles and their applications in the delivery of a number of active agents. Increasing experience in the field of preparation, characterization, and in vivo application of PLGA nanoparticles has provided the necessary momentum for promising future use of these agents in cancer treatment, with higher efficacy and fewer side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Nanocapsule formation by interfacial polymer deposition following solvent displacement
Fessi, H., Puisieux, F., Devissaguet, J. P., Ammoury, N., & Benita, S. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90281-0 · Cited by 2,288
Jain, R. A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00115-0 · Cited by 2,214
Girois, S., Audouin, L., Jacques Verdu, C., Delprat, P., & Marot, G. (1996) · Cited by 2,213
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Hyperthermia in combined treatment of cancer
Wust, P., Hildebrandt, B., Sreenivasa, G., Rau, B., Gellermann, J., Riess, H., Felix, R., & Schlag, P. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00818-5 · Cited by 1,998
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles
O'Neal, D. P., Hirsch, L. R., Halas, N. J., Payne, J. D., & West, J. L. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.02.004 · Cited by 1,849
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Athanasiou, K. A., Niederauer, G. G., & Agrawal, C. M. (1996) · Biomaterials · doi:10.1016/0142-9612(96)85754-1 · Cited by 1,497
Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474
Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1
Gilding, D. K., & Reed, A. M. (1979) · Polymer · doi:10.1016/0032-3861(79)90009-0 · Cited by 1,345
Formulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery
Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.047 · Cited by 1,273
Design and production of nanoparticles formulated from nano-emulsion templates-A review
Anton, N., Benoit, J.-P., & Saulnier, P. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.02.007 · Cited by 1,226
Heating the patient: a promising approach?
van der Zee, J. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf280 · Cited by 1,220
Polymers for the sustained release of proteins and other macromolecules
LANGER, R., & FOLKMAN, J. (1976) · Nature · doi:10.1038/263797a0 · Cited by 1,182
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
Gaumet, M., Vargas, A., Gurny, R., & Delie, F. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.001 · Cited by 1,081
Panyam, J., Zhou, W., Prabha, S., Sahoo, S. K., & Labhasetwar, V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0088com · Cited by 1,044
Govender, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00116-3 · Cited by 1,008
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.006 · Cited by 956
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
Vauthier, C., & Bouchemal, K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9800-3 · Cited by 929
Current advances in research and clinical applications of PLGA-based nanotechnology
Lü, J.-M., Wang, X., Marin-Muller, C., Wang, H., Lin, P. H., Yao, Q., & Chen, C. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.15 · Cited by 903
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 877
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.033 · Cited by 796
Synthesis and characterization of PLGA nanoparticles
Astete, C. E., & Sabliov, C. M. (2006) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856206775997322 · Cited by 776
Fonseca, C., Simões, S., & Gaspar, R. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00212-2 · Cited by 755
PLGA Nanoparticles in Drug Delivery: The State of the Art;
Bala, I., Hariharan, S., & Kumar, M. R. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i5.20 · Cited by 739
Mu, L., & Feng, S. S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00320-6 · Cited by 725
Curcumin: Getting Back to the Roots
SHISHODIA, S., SETHI, G., & AGGARWAL, B. B. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1352.010 · Cited by 715
Albumin-bound paclitaxel: a next-generation taxane
Gradishar, W. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1041 · Cited by 712
Long circulating microparticulate drug carriers
Stolnik, S., Illum, L., & Davis, S. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00025-3 · Cited by 700
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
Tomao, S. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s3061 · Cited by 695
Green, M. R., Manikhas, G. M., Orlov, S., Afanasyev, B., Makhson, A. M., Bhar, P., & Hawkins, M. J. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl104 · Cited by 667
Folate receptor targeted biodegradable polymeric doxorubicin micelles
Yoo, H. S., & Park, T. G. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.003 · Cited by 620
Safra, T., Muggia, F., Jeffers, S., Tsao-Wei, D. D., Groshen, S., Lyass, O., Henderson, R., Berry, G., & Gabizon, A. (2000) · Annals of Oncology · doi:10.1023/a:1008365716693 · Cited by 618
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Danhier, F., Lecouturier, N., Vroman, B., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.086 · Cited by 616
Jung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 588
Yallapu, M. M., Gupta, B. K., Jaggi, M., & Chauhan, S. C. (2010) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2010.05.022 · Cited by 579
Mittal, G., Sahana, D. K., Bhardwaj, V., & Ravi Kumar, M. N. V. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.016 · Cited by 551
Tumour-targeted nanomedicines: principles and practice
Lammers, T., Hennink, W. E., & Storm, G. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604483 · Cited by 542
PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats
Li, Y.-P., Pei, Y.-Y., Zhang, X.-Y., Gu, Z.-H., Zhou, Z.-H., Yuan, W.-F., Zhou, J.-J., Zhu, J.-H., & Gao, X.-J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00218-8 · Cited by 540
Panyam, J., Dali, M. M., Sahoo, S. K., Ma, W., Chakravarthi, S. S., Amidon, G. L., Levy, R. J., & Labhasetwar, V. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00328-6 · Cited by 529
Bastida, Á., Sabuquillo, P., Armisén, P., Fernández‐Lafuente, R., Huguet, J., & Guisan, J. M. (1998) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19980605)58:5<529::aid-bit9>3.0.co;2-f · Cited by 528
Characterization of nanoparticle uptake by endothelial cells
Davda, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00923-1 · Cited by 524
Avgoustakis, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00530-2 · Cited by 503
Preparation and characterization of cationic PLGA nanospheres as DNA carriers
Ravi Kumar, M. N. V., Bakowsky, U., & Lehr, C. M. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.08.069 · Cited by 492
Which polymers can make nanoparticulate drug carriers long-circulating?
Torchilin, V. P., & Trubetskoy, V. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00022-y · Cited by 480
Drug-loaded nanoparticles : preparation methods and drug targeting issues
Allémann, É., Gurny, R., & Doelker, É. (1993) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 454
Dunne, M., Corrigan, O. I., & Ramtoola, Z. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00040-5 · Cited by 444
Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee, A., & Vishwanatha, J. K. (2009) · PubMed · Cited by 444
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody
Kocbek, P., Obermajer, N., Cegnar, M., Kos, J., & Kristl, J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.012 · Cited by 436
PLA/PLGA nanoparticles for sustained release of docetaxel
Musumeci, T., Ventura, C. A., Giannone, I., Ruozi, B., Montenegro, L., Pignatello, R., & Puglisi, G. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.023 · Cited by 435
Mucoadhesive nanoparticulate systems for peptide drug delivery.
Takéuchi, Hirofumi, Yamamoto, Y., Hiromitsu, Kawashima, & Yoshiaki (2002) · 岐阜藥科大學紀要 = The annual proceedings of Gifu College of Pharmacy · Cited by 432
Polymeric nanoparticles for cancer therapy
Parveen, S., & Sahoo, S. K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860701794353 · Cited by 427
Murakami, H., Kobayashi, M., Takeuchi, H., & Kawashima, Y. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00187-8 · Cited by 405
Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs
Dong, Y., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.03.021 · Cited by 395
Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours
Russell-Jones, G., McTavish, K., McEwan, J., Rice, J., & Nowotnik, D. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.07.009 · Cited by 392
Lyass, O., Uziely, B., Ben-Yosef, R., Tzemach, D., Heshing, N. I., Lotem, M., Brufman, G., & Gabizon, A. (2000) · Cancer · doi:10.1002/1097-0142(20000901)89:5<1037::aid-cncr13>3.0.co;2-z · Cited by 385
In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin–PLGA conjugates
Yoo, H. S., Lee, K. H., Oh, J. E., & Park, T. G. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00280-7 · Cited by 374
Tobı́o, M., Sánchez, A., Vila, A., Soriano, I., Evora, C., Vila-Jato, J. L., & Alonso, M. J. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00157-5 · Cited by 368
Degradation of poly (D,L-lactic acid) microspheres: Effect of molecular weight
Park, T. G. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90263-1 · Cited by 359
How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.
Gottesman, M. M. (1993) · PubMed · Cited by 352
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
Danhier, F., Vroman, B., Lecouturier, N., Crokart, N., Pourcelle, V., Freichels, H., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.011 · Cited by 335
Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy
Acharya, S., Dilnawaz, F., & Sahoo, S. K. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.008 · Cited by 333
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.021 · Cited by 331
Mosqueira, V. C. F., Legrand, P., Gulik, A., Bourdon, O., Gref, R., Labarre, D., & Barratt, G. (2001) · Biomaterials · doi:10.1016/s0142-9612(01)00043-6 · Cited by 325
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z. (., & Shin, D. M. (2009) · Nanoscience and Technology · doi:10.1142/9789814287005_0025 · Cited by 321
Panyam, J., Williams, D., Dash, A., Leslie‐Pelecky, D., & Labhasetwar, V. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20094 · Cited by 320
Patil, Y., Sadhukha, T., Ma, L., & Panyam, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.021 · Cited by 317
Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel
Kim, J.-H., Kim, Y.-S., Kim, S., Park, J. H., Kim, K., Choi, K., Chung, H., Jeong, S. Y., Park, R.-W., Kim, I.-S., et al. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.12.013 · Cited by 313
Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel
Feng, S.-S., Mu, L., Win, K., & Huang, G. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455909 · Cited by 311
(2024) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-031-52864-4 · Cited by 309
Ishida, O., Maruyama, K., Sasaki, K., & Iwatsuru, M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00256-2 · Cited by 308
Panyam, J., Sahoo, S. K., Prabha, S., Bargar, T., & Labhasetwar, V. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00295-3 · Cited by 308
Patil, Y. B., Swaminathan, S. K., Sadhukha, T., Ma, L., & Panyam, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.048 · Cited by 304
Targeting cancer cells with biotin–dendrimer conjugates
Yang, W., Cheng, Y., Xu, T., Wang, X., & Wen, L.-P. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.04.021 · Cited by 290
Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method
Kwon, H.-Y., Lee, J.-Y., Choi, S.-W., Jang, Y., & Kim, J.-H. (2001) · Colloids and Surfaces A: Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(00)00825-6 · Cited by 286
Therapeutic applications of colloidal drug carriers
Barratt, G. M. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00255-8 · Cited by 282
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles
Konan, Y. N., Gurny, R., & Allémann, E. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00944-9 · Cited by 279
Sun, B., Ranganathan, B., & Feng, S.-S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.09.038 · Cited by 274
Encapsulation of dexamethasone into biodegradable polymeric nanoparticles
GOMEZGAETE, C., TSAPIS, N., BESNARD, M., BOCHOT, A., & FATTAL, E. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.028 · Cited by 259
Betancourt, T., Brown, B., & Brannon-Peppas, L. (2007) · Nanomedicine · doi:10.2217/17435889.2.2.219 · Cited by 249
Kim, S. H., Jeong, J. H., Chun, K. W., & Park, T. G. (2005) · Langmuir · doi:10.1021/la0502084 · Cited by 242
Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery
Zhang, Z., Huey Lee, S., & Feng, S.-S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.12.018 · Cited by 238
The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity
Yan, F., Zhang, C., Zheng, Y., Mei, L., Tang, L., Song, C., Sun, H., & Huang, L. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.05.004 · Cited by 238
Kim, S. Y., & Lee, Y. M. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00292-1 · Cited by 227
Targeted Nanomedicines: Effective Treatment Modalities for Cancer, AIDS and Brain Disorders
Muthu, M. S., & Singh, S. (2009) · Nanomedicine · doi:10.2217/17435889.4.1.105 · Cited by 225
Influence of Crystallinity and Stereochemistry on the Enzymatic Degradation of Poly(lactide)s
Li, S., & McCarthy, S. (1999) · Macromolecules · doi:10.1021/ma990117b · Cited by 211
Song, X. R., Cai, Z., Zheng, Y., He, G., Cui, F. Y., Gong, D. Q., Hou, S. X., Xiong, S. J., Lei, X. J., & Wei, Y. Q. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.018 · Cited by 211
Peracchia, M. T., Harnisch, S., Pinto-Alphandary, H., Gulik, A., Dedieu, J. C., Desmaële, D., d’Angelo, J., Müller, R. H., & Couvreur, P. (1999) · Biomaterials · doi:10.1016/s0142-9612(99)00021-6 · Cited by 208
Schliecker, G., Schmidt, C., Fuchs, S., & Kissel, T. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00243-6 · Cited by 208
Nanoparticles of biodegradable polymers for new-concept chemotherapy
Feng, S.-S. (2004) · Expert Review of Medical Devices · doi:10.1586/17434440.1.1.115 · Cited by 206
Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA–PEG–folate conjugate
Esmaeili, F., Ghahremani, M. H., Ostad, S. N., Atyabi, F., Seyedabadi, M., Malekshahi, M. R., Amini, M., & Dinarvand, R. (2008) · Journal of Drug Targeting · doi:10.1080/10611860802088630 · Cited by 203
Self-citationChoi, S.-W., & Kim, J.-H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.003 · Cited by 196
Quantifying drug release from PLGA nanoparticulates
Corrigan, O. I., & Li, X. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.04.004 · Cited by 195
Shenoy, D., Little, S., Langer, R., & Amiji, M. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0500420 · Cited by 193
Lamprecht, A., Ubrich, N., Hombreiro Pérez, M., Lehr, C.-M., Hoffman, M., & Maincent, P. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00422-6 · Cited by 185
Song, K. C., Lee, H. S., Choung, I. Y., Cho, K. I., Ahn, Y., & Choi, E. J. (2006) · Colloids and Surfaces A: Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2005.10.064 · Cited by 183
Uskokovic, D., & Stevanovic, M. (2009) · Current Nanoscience · doi:10.2174/157341309787314566 · Cited by 182
Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer
Zeisser-Labouèbe, M., Lange, N., Gurny, R., & Delie, F. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.012 · Cited by 180
Stability and freeze-drying of cyclosporine loaded poly(d,l lactide–glycolide) carriers
Chacón, M., Molpeceres, J., Berges, L., Guzmán, M., & Aberturas, M. R. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(98)00066-9 · Cited by 178
Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles
Dillen, K., Vandervoort, J., Van den Mooter, G., Verheyden, L., & Ludwig, A. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.033 · Cited by 175
Manuela Gaspar, M., Blanco, D., Cruz, M. E. M., & José Alonso, M. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00196-x · Cited by 175
Thioune, O., Fessi, H., Devissaguet, J. P., & Puisieux, F. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04830-2 · Cited by 161
Esmaeili, F., Ghahremani, M. H., Esmaeili, B., Khoshayand, M. R., Atyabi, F., & Dinarvand, R. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.038 · Cited by 159
Self-citationPolymers in Drug Delivery—State of the Art and Future Trends
Grund, S., Bauer, M., & Fischer, D. (2011) · Advanced Engineering Materials · doi:10.1002/adem.201080088 · Cited by 158
Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use
Ricci‐Júnior, E., & Marchetti, J. M. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.048 · Cited by 157
Konan, Y. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00128-5 · Cited by 152
Esmaeili, F., Hosseini-Nasr, M., Rad‐Malekshahi, M., Samadi, N., Atyabi, F., & Dinarvand, R. (2007) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2007.03.003 · Cited by 150
Self-citationWin, K. Y., & Feng, S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.11.008 · Cited by 150
Soundararajan, A., Bao, A., Phillips, W. T., Perez, R., & Goins, B. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.02.004 · Cited by 145
Bhardwaj, V., Ankola, D. D., Gupta, S., Schneider, M., Lehr, C., & Kumar, M. N. V. R. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9965-4 · Cited by 145
Song, C. X., Labhasetwar, V. D., Cui, X., Underwood, T., & Levy, R. J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00016-9 · Cited by 144
van Vlerken, L. E., Duan, Z., Little, S. R., Seiden, M. V., & Amiji, M. M. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800030k · Cited by 144
Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes
Cheng, F., Wang, S. P.-H., Su, C.-H., Tsai, T.-L., Wu, P., Shieh, D.-B., Chen, J., Hsieh, P. C. H., & Yeh, C. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.01.010 · Cited by 142
Manchanda, R., Fernandez-Fernandez, A., Nagesetti, A., & McGoron, A. J. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.08.043 · Cited by 140
Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells
Gryparis, E. C., Hatziapostolou, M., Papadimitriou, Ε., & Avgoustakis, K. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.12.017 · Cited by 139
Prior, S., Gander, B., Blarer, N., Merkle, H. P., Subirá, M. L., Irache, J. M., & Gamazo, C. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00218-4 · Cited by 138
Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy
Lammers, T., Šubr, V., Ulbrich, K., Hennink, W. E., Storm, G., & Kiessling, F. M. (2010) · Nano Today · doi:10.1016/j.nantod.2010.05.001 · Cited by 137
Zheng, Y., Yu, B., Weecharangsan, W., Piao, L., Darby, M. V., Mao, Y., Koynova, R. D., Yang, X., Li, H., Xu, S., et al. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.02.008 · Cited by 133
Dong, Y., & Feng, S. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.031 · Cited by 132
Mo, Y., & Lim, L. Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.024 · Cited by 128
Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux
Chavanpatil, M. D., Patil, Y. B., & Panyam, J. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.045 · Cited by 124
Minko, T., Paranjpe, P. V., Qiu, B., Lalloo, A., Won, R., Stein, S., & Sinko, P. J. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0463-1 · Cited by 120
Zhang, Z., Lee, S. H., Gan, C. W., & Feng, S. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9611-6 · Cited by 117
Shah, N., Chaudhari, K., Dantuluri, P., Murthy, R. S. R., & Das, S. (2009) · Journal of drug targeting · doi:10.1080/10611860903046628 · Cited by 114
Aqueous nanodispersions prepared by a salting-out process
Ibrahim, H., Bindschaedler, C., Doelker, É., Buri, P. A., & Gurny, R. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90248-z · Cited by 110
Moinard-Chécot, D., Chevalier, Y., Briançon, S., et al. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.479 · Cited by 109
Yellepeddi, V., Kumar, A., & Palakurthi, S. (2009) · PubMed · Cited by 100
Wang, Z., Chui, W., & Ho, P. C. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9837-y · Cited by 100
Xie, J., & Wang, C. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7782-y · Cited by 99
Ma, Y., Zheng, Y., Liu, K., Tian, G., Tian, Y., Xu, L., Yan, F., Huang, L., & Mei, L. (2010) · Nanoscale Research Letters · doi:10.1007/s11671-010-9620-3 · Cited by 99
Mattheolabakis, G., Taoufik, E., Haralambous, S., Roberts, M. L., & Avgoustakis, K. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.011 · Cited by 98
Dong, Y., & Feng, S. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30684 · Cited by 81
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid
Bondioli, L., Costantino, L., Ballestrazzi, A., Lucchesi, D., Boraschi, D., Pellati, F., Benvenuti, S., Tosi, G., & Vandelli, M. A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.049 · Cited by 75
Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy
Chen, H., Zheng, Y., Tian, G., Tian, Y., Zeng, X., Liu, G., Liu, K., Li, L., Li, Z., Mei, L., et al. (2010) · Nanoscale Research Letters · doi:10.1007/s11671-010-9741-8 · Cited by 72
Utreja, P., Jain, S. K., & Tiwary, A. K. (2010) · Current Drug Delivery · doi:10.2174/156720110791011783 · Cited by 70
YANG, A., Yang, L., Liu, W., Li, Z., Xu, H. E., & Yang, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.09.015 · Cited by 69
Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66
Rosas, J. E., Hernández, R. M., Rodríguez‐Gascón, A., Igartúa, M., Guzmán, F., Patarroyo, M. E., & Pedraz, J. L. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00192-x · Cited by 67
G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method
Choi, S. H., & Park, T. G. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.12.023 · Cited by 66
Zhang, H., Cui, W., Bei, J., & Wang, S. (2006) · Polymer Degradation and Stability · doi:10.1016/j.polymdegradstab.2006.03.004 · Cited by 62
Ricci‐Júnior, E., & Marchetti, J. M. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600775525 · Cited by 61
Esmaeili, F., Dinarvand, R., Ghahremani, M. H., Ostad, S. N., Esmaily, H., & Atyabi, F. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328331f934 · Cited by 49
Self-citationFeng, S., Li, M., Chen, B., & Pack, D. W. (2002) · Materials Science and Engineering C · doi:10.1016/s0928-4931(02)00017-6 · Cited by 49
He, X., Ma, J., Mercado‐Pagán, Á. E., Xu, W., & Jabbari, E. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9513-z · Cited by 47
Kou, G., Gao, J., Wang, H., Chen, H., Li, B., Zhang, D., Wang, S., Hou, S., Qian, W., Dai, J., et al. (2007) · BMB Reports · doi:10.5483/bmbrep.2007.40.5.731 · Cited by 45
Esmaeili, F., Atyabi, F., & Dinarvand, R. (2007) · Journal of Experimental Nanoscience · doi:10.1080/17458080701393137 · Cited by 39
Self-citationDong, Y., & Feng, S. (2014) · doi:10.1201/b15645-16 · Cited by 5
Cited by
Targeted drug delivery strategies for precision medicines
Manzari, M. T., Shamay, Y., Kiguchi, H., Rosen, N., Scaltriti, M., & Heller, D. A. (2021) · Nature Reviews Materials · doi:10.1038/s41578-020-00269-6 · Cited by 1,183
Elmowafy, E. M., Tiboni, M., & Soliman, M. E. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00439-x · Cited by 621
PLGA-Based Nanoparticles in Cancer Treatment
Rezvantalab, S., Drude, N. I., Moraveji, M. K., Güvener, N., Koons, E. K., Shi, Y., Lammers, T., & Kiessling, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01260 · Cited by 607
Vitamin E TPGS as a molecular biomaterial for drug delivery
Zhang, Z., Tan, S., & Feng, S.-S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.046 · Cited by 586
Double emulsion solvent evaporation techniques used for drug encapsulation
Iqbal, M., Zafar, N., Fessi, H., & Elaissari, A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.10.057 · Cited by 560
Metadata
- Authors
- Dinarvand, R., Sepehri, N., Manouchehri, Rouhani, & Atyabi, F.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2011-04
- Volume
- 6
- Pages
- 877
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W1977718036
- Cited by
- 453
- References
- 158
- FWCI
- 11.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.